twiist

Abbott Receives U.S. Authorization for Sensor That Monitors Glucose and Ketones Together

The U.S. Food and Drug Administration granted Abbott de novo authorization for the Libre Duo 10 Day wearable sensor, which can continuously monitor glucose and ketones in people with diabetes. The company plans to launch it in the United States during 2026, while its price and insurance coverage remain undisclosed.